Metabolism of dextromethorphan in human liver microsomes: A rapid HPCL assay to monitor cytochrome P450 2D6 activity

被引:0
|
作者
Vielnascher, E
Spatzenegger, M
Mayrhofer, A
Klinger, P
Jager, W
机构
[1] UNIV VIENNA, INST PHARMACEUT CHEM, A-1090 VIENNA, AUSTRIA
[2] NATL INST QUAL CONTROL DRUGS, VIENNA, AUSTRIA
[3] UNIV INNSBRUCK, DEPT SURG 2, A-6020 INNSBRUCK, AUSTRIA
来源
PHARMAZIE | 1996年 / 51卷 / 08期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new HPLC assay was developed to study dextromethorphan O-demethylation to dextrophan in vitro using human liver microsomes to investigate the activity of the polymorphic monooxygenase cytochrome P450 2D6 (CYP 2D6). The separation of dextromethorphan and its main metabolite dextrorphan was performed on a polymeric C18 reversed-phase column with UV-detection using levallorphan as an internal standard. Liver samples from ten subjects were screened for dextrorphan formation whereby three groups with different abilities to metabolize dextromethorphan could be found. Seven microsomal preparations from extensive metabolizers showed an average dextrorphan formation rate of 298 +/- 68 pmol/mg protein . min, one sample was classified to belong to an intermediate dextromethorphan metabolizer (79 pmol/mg protein min), whereas two samples of poor metabolizers exhibited significantly lower rates of dextromethorphan metabolism with values of 11 and 27 pmol/mg protein . min, respectively. This assay permits not only a fast in vitro screening for cytochrome P450 2D6 monooxygenase activity but is also an excellant tool to determine potential drug-drug interactions with this important metabolizing enzyme.
引用
收藏
页码:586 / 588
页数:3
相关论文
共 50 条
  • [1] Cytochrome P450 2D6
    Owen, Ryan P.
    Sangkuhl, Katrin
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (07): : 559 - 562
  • [2] Cytochrome P450 2D6 (CYP2D6) activity in relation to the antitussive effect of dextromethorphan
    Abdul-Manap, R
    Wright, CE
    Rostami-Hodjegan, A
    Meller, S
    Lennard, MS
    Morice, AH
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (05) : 586 - 587
  • [3] The role of cytochrome P450 2D6 in the metabolism of moclobemide
    Hartter, S
    Dingemanse, J
    Baier, D
    Ziegler, G
    Hiemke, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (03) : 225 - 230
  • [4] Human liver cytochrome P450 2D6 genotype, full-length messenger ribonucleic acid, and activity assessed with a novel cytochrome P450 2D6 substrate
    McConnachie, L
    Bodor, M
    Kowdley, K
    Levy, A
    Tung, B
    Thummel, K
    Phillips, B
    Bajpai, M
    Chi, V
    Esmay, JD
    Shen, DA
    Ho, RJY
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (04) : 282 - 297
  • [5] Metabolism of Sesamin by Cytochrome P450 in Human Liver Microsomes
    Yasuda, Kaori
    Ikushiro, Shinichi
    Kamakura, Masaki
    Ohta, Miho
    Sakaki, Toshiyuki
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (12) : 2117 - 2123
  • [6] Effect of age on the activity of cytochrome P450 2D6 using dextromethorphan phenotyping in humans.
    Park, J
    Kim, K
    Park, P
    Lee, D
    Kim, H
    Park, C
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P24 - P24
  • [7] Cytochrome P450 2D6 activity in human liver microsomes: Assessment of drug metabolizing enzyme lability as a function of incubation conditions
    Foti, RS
    Fisher, MB
    DRUG METABOLISM REVIEWS, 2002, 34 : 102 - 102
  • [8] Crystal structure of human cytochrome P450 2D6
    Rowland, P
    Blaney, FE
    Smyth, MG
    Jones, JJ
    Leydon, VR
    Oxbrow, AK
    Lewis, CJ
    Tennant, MG
    Modi, S
    Eggleston, DS
    Chenery, RJ
    Bridges, AM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7614 - 7622
  • [9] Measurement of human liver microsomal cytochrome P450 2D6 activity using [O-methyl-C-14]dextromethorphan as substrate
    Rodrigues, AD
    CYTOCHROME P450, PT B, 1996, 272 : 186 - 195
  • [10] Rapid and reliable method for cytochrome P450 2D6 genotyping
    Stamer, UM
    Bayerer, B
    Wolf, S
    Hoeft, A
    Stüber, F
    CLINICAL CHEMISTRY, 2002, 48 (09) : 1412 - 1417